Intellia Therapeutics, Inc. (NTLA)

Typically moves ±6.04% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-14 APPROXIMATE

Intellia Therapeutics, Inc. (NTLA) has a 41-report earnings history dating back to Aug 04, 2016. Its average absolute post-earnings move is ±6.04%, and 51.2% of those reactions were positive. Its largest post-earnings gain was +14.33% (Aug 04, 2016) and its largest decline was -22.73% (Nov 06, 2025). The next earnings report is predicted for 2026-08-14 (approximate).

Earnings reactions

How NTLA moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.04%

Positive %

51.2%

Negative %

48.8%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 11, 2026	☀ PRE	+2.52%	open_in_new
Apr 30, 2026	☽ POST	-1.74%	open_in_new
Feb 26, 2026	☀ PRE	+6.41%	open_in_new
Nov 06, 2025	☽ POST	-22.73%	open_in_new
Aug 07, 2025	☀ PRE	+0.79%	open_in_new
May 08, 2025	☀ PRE	+13.58%	open_in_new
Feb 27, 2025	☀ PRE	+0.56%	open_in_new
Nov 07, 2024	☀ PRE	-0.37%	open_in_new
Aug 08, 2024	☀ PRE	+5.02%	open_in_new
May 09, 2024	☀ PRE	+8.09%	open_in_new
Feb 22, 2024	☀ PRE	+1.12%	open_in_new
Nov 09, 2023	☀ PRE	-12.27%	open_in_new
Aug 03, 2023	☀ PRE	-1.56%	open_in_new
May 04, 2023	☀ PRE	+13.14%	open_in_new
Feb 23, 2023	☀ PRE	+0.08%	open_in_new
Nov 03, 2022	☀ PRE	+1%	open_in_new
Aug 04, 2022	☀ PRE	-8.74%	open_in_new
May 05, 2022	☀ PRE	-10.18%	open_in_new
Feb 24, 2022	☀ PRE	+9.26%	open_in_new
Nov 04, 2021	☀ PRE	-1.45%	open_in_new
Aug 05, 2021	☀ PRE	+12.4%	open_in_new
May 06, 2021	☀ PRE	-6.84%	open_in_new
Feb 25, 2021	☀ PRE	-9.81%	open_in_new
Nov 05, 2020	☀ PRE	+4.82%	open_in_new
Aug 06, 2020	☀ PRE	+1.73%	open_in_new
May 07, 2020	☀ PRE	-1.44%	open_in_new
Feb 27, 2020	☀ PRE	-5.57%	open_in_new
Oct 31, 2019	☀ PRE	+6.07%	open_in_new
Aug 01, 2019	☀ PRE	-0.06%	open_in_new
May 02, 2019	☀ PRE	+2.49%	open_in_new
Feb 27, 2019	☀ PRE	+6.34%	open_in_new
Oct 31, 2018	☀ PRE	-8.32%	open_in_new
Aug 01, 2018	☀ PRE	-3.16%	open_in_new
May 01, 2018	☀ PRE	+2.7%	open_in_new
Mar 14, 2018	☀ PRE	-13.28%	open_in_new
Oct 31, 2017	☀ PRE	+8.89%	open_in_new
Aug 01, 2017	☀ PRE	-4.33%	open_in_new
May 02, 2017	☀ PRE	-4.97%	open_in_new
Mar 14, 2017	☀ PRE	-4.9%	open_in_new
Nov 01, 2016	☽ POST	-4.42%	open_in_new
Aug 04, 2016	☽ POST	+14.33%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.04%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 22 →

Funds holding

$404716126

Total value held

Buying

18 added · 2 reduced

Blackrock, Inc.

$155837437 +18.28%

State Street Corp

$88748706 +7.85%

Regeneron Pharmaceuticals, Inc.

$47472396 Held

Morgan Stanley

$26683520 -10.59%

Goldman Sachs Group Inc

$20874050 +11.86%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260706	open_in_new SEC.gov
4	20260706	open_in_new SEC.gov
144	20260702	open_in_new SEC.gov
8-K	20260615	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov

Frequently asked about NTLA earnings

When does Intellia Therapeutics, Inc. report earnings next? expand_more

Intellia Therapeutics, Inc. (NTLA)'s next earnings date is approximate for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does NTLA stock move after earnings? expand_more

Over 41 reports, NTLA has moved an average of ±6.04% the session after earnings, closing higher 51.2% of the time.

What was NTLA's biggest post-earnings move? expand_more

NTLA's largest post-earnings gain on record was +14.33% on Aug 04, 2016, and its largest decline was -22.73% on Nov 06, 2025.

Where can I find Intellia Therapeutics, Inc.'s SEC filings? expand_more

All of Intellia Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.